IMVT
Immunovant, Inc. · Healthcare
Chief Executive Officer Eric Venker sold $120K of Immunovant, Inc.
Sold$119,590
$34.11Price
3,506Shares
−1%Stake
What IMVT did after the filing
- The stock from Tue, Oct 6 open, $33.51
- −15.2%
- S&P 500, same days
- −2.3%
13 of 30 trading days so far, to the Oct 23 close.
Traded Fri, Oct 2. Filed Mon, Oct 5, 7:42 PM ET, after the close. Returns use the Oct 6 open and the Oct 23 close. Not investment advice.